StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)

Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%

Zimmer Biomet ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Zimmer Biomet's ebitda for the twelve months ending Jun 30, 2026 was $2.31B, up 0.5% year over year. For fiscal 2025 it was $2.19B, down 3.9% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $2.28B in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.19B-3.9%
FY2024Dec 31, 2024$2.28B+2.4%
FY2023Dec 31, 2023$2.23B+37.4%
FY2022Dec 31, 2022$1.62B-9.7%
FY2021Dec 31, 2021$1.80B+83.2%
FY2020Dec 31, 2020$981.50M-54.2%
FY2019Dec 31, 2019$2.14B+99.5%
FY2018Dec 31, 2018$1.07B-42.3%
FY2017Dec 31, 2017$1.86B+0.1%
FY2016Dec 31, 2016$1.86B+57.7%
FY2015Dec 31, 2015$1.18B-16.5%
FY2014Dec 31, 2014$1.41B-1.0%
FY2013Dec 31, 2013$1.43B+1.2%
FY2012Dec 31, 2012$1.41B+1.9%
FY2011Dec 31, 2011$1.38B+10.1%
FY2010Dec 31, 2010$1.26B-7.3%
FY2009Dec 31, 2009$1.36B-0.7%
FY2008Dec 31, 2008$1.37B+0.6%
FY2007Dec 31, 2007$1.36B–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$596.90M+4.4%
Q1 FY2026Mar 31, 2026$643.20M+17.7%
Q4 FY2025Dec 31, 2025$438.50M-32.8%
Q3 FY2025Sep 30, 2025$634.90M+19.7%
Q2 FY2025Jun 30, 2025$571.80M-3.8%
Q1 FY2025Mar 31, 2025$546.70M+8.4%
Q4 FY2024Dec 31, 2024$652.60M+9.6%
Q3 FY2024Sep 30, 2024$530.40M+4.5%
Q2 FY2024Jun 30, 2024$594.60M+4.8%
Q1 FY2024Mar 31, 2024$504.50M-9.8%
Q4 FY2023Dec 31, 2023$595.40M+197.4%
Q3 FY2023Sep 30, 2023$507.80M+6.5%
Q2 FY2023Jun 30, 2023$567.10M+10.4%
Q1 FY2023Mar 31, 2023$559.10M+29.4%
Q4 FY2022Dec 31, 2022$200.20M-45.4%
Q3 FY2022Sep 30, 2022$476.70M+0.1%
Q2 FY2022Jun 30, 2022$513.60M+11.5%
Q1 FY2022Mar 31, 2022$432.20M-12.6%
Q4 FY2021Dec 31, 2021$367.00M-32.4%
Q3 FY2021Sep 30, 2021$476.00M-14.7%
Q2 FY2021Jun 30, 2021$460.60M+448.3%
Q1 FY2021Mar 31, 2021$494.40M–
Q4 FY2020Dec 31, 2020$542.70M-8.1%
Q3 FY2020Sep 30, 2020$557.80M+12.2%
Q2 FY2020Jun 30, 2020$84.00M-81.6%
Q1 FY2020Mar 31, 2020-$203.00M-134.0%
Q4 FY2019Dec 31, 2019$590.70M–
Q3 FY2019Sep 30, 2019$497.30M+2.8%
Q2 FY2019Jun 30, 2019$457.70M-17.9%
Q1 FY2019Mar 31, 2019$597.90M+5.2%
Q4 FY2018Dec 31, 2018-$535.70M-338.7%
Q3 FY2018Sep 30, 2018$483.90M+1.3%
Q2 FY2018Jun 30, 2018$557.60M+2.5%
Q1 FY2018Mar 31, 2018$568.50M-7.7%
Q4 FY2017Dec 31, 2017$224.40M-47.9%
Q3 FY2017Sep 30, 2017$477.70M-1.2%
Q2 FY2017Jun 30, 2017$544.20M–
Q1 FY2017Mar 31, 2017$615.70M–
Q4 FY2016Dec 31, 2016$430.50M–
Q3 FY2016Sep 30, 2016$483.60M–

More Zimmer Biomet figures

See a number that looks wrong?